Skip to content
Sign in

BMY · NYSE

Bristol-Myers Squibb (BMY) Stock Price & Fundamentals

$357.68+1.07%+$3.79End-of-day price as of Oct 9, 2026

Bristol-Myers Squibb (BMY) closed at $357.68 on Oct 9, 2026, up 1.07% from the previous close of $353.89.

Share price, past year

1Y +53.53%

52-week range $232.97 – $357.68. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$357.68
Sep 30, 2026$348.57
Aug 31, 2026$332.06
Jul 31, 2026$304.36
Jun 30, 2026$308.39
May 29, 2026$306.62
Apr 30, 2026$295.19
Mar 31, 2026$283.50
Feb 27, 2026$272.17
Jan 30, 2026$270.56
Dec 31, 2025$263.17
Nov 28, 2025$255.16
Oct 31, 2025$244.17

Key statistics

Market cap
$730.64B
P/E (TTM)
78.6
EPS (TTM)
$4.55
Revenue (TTM)
$49.19B
Net income (TTM)
$9.28B
Shares outstanding
2B
Dividend yield
0.70%
52-week range
$232.97 – $357.68

Bristol-Myers Squibb's market cap is $730.64B, based on a share price of $357.68 and 2B shares outstanding as of Jul 22, 2026.

Financials

Bristol-Myers Squibb reported revenue of $48.19B for fiscal 2025, down 0.22% from fiscal 2024.

Bristol-Myers Squibb earned net income of $7.05B in fiscal 2025, a net margin of 14.6%.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Bristol-Myers Squibb annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$48.19B−0.2%$7.05B14.6%$3.46$12.85B
FY2024ended Dec 31, 2024$48.30B+7.3%−$8.95B−18.5%−$4.41$13.94B
FY2023ended Dec 31, 2023$45.01B−2.5%$8.03B17.8%$3.86$12.65B
FY2022ended Dec 31, 2022$46.16B−0.5%$6.33B13.7%$2.95$11.95B
FY2021ended Dec 31, 2021$46.39B+9.1%$6.99B15.1%$3.12$15.23B
FY2020ended Dec 31, 2020$42.52B+62.6%−$9.02B−21.2%−$3.99$13.30B
FY2019ended Dec 31, 2019$26.15B+15.9%$3.44B13.2%$2.01$7.37B
FY2018ended Dec 31, 2018$22.56B+8.6%$4.92B21.8%$3.01$6.12B
FY2017ended Dec 31, 2017$20.78B+6.9%$1.01B4.9%$0.61$4.22B
FY2016ended Dec 31, 2016$19.43B—$4.46B22.9%$2.65$1.84B
Bristol-Myers Squibb quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$12.97B$3.32B$1.62
Q1 FY2026ended Mar 31, 2026$11.49B$2.68B$1.31
Q4 FY2025ended Dec 31, 2025$12.50B$1.09B$0.54
Q3 FY2025ended Sep 30, 2025$12.22B$2.20B$1.08
Q2 FY2025ended Jun 30, 2025$12.27B$1.31B$0.64
Q1 FY2025ended Mar 31, 2025$11.20B$2.46B$1.20
Q4 FY2024ended Dec 31, 2024$12.34B$72.00M$0.05
Q3 FY2024ended Sep 30, 2024$11.89B$1.21B$0.60

Company profile

Name
Bristol-Myers Squibb Company
Ticker
BMY
Exchange
NYSE
Industry (SEC SIC)
Pharmaceutical Preparations
Headquarters
Route 206 And Province Line Road, Princeton, NJ 08543
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0000014272

Recent SEC filings

Frequently asked questions

What is Bristol-Myers Squibb's stock price?

Bristol-Myers Squibb (BMY) closed at $357.68 on Oct 9, 2026, up 1.07% from the previous close of $353.89.

What is Bristol-Myers Squibb's market cap?

Bristol-Myers Squibb's market cap is $730.64B, based on a share price of $357.68 and 2B shares outstanding as of Jul 22, 2026.

How much revenue does Bristol-Myers Squibb make?

Bristol-Myers Squibb reported revenue of $48.19B for fiscal 2025, down 0.22% from fiscal 2024.

What is BMY's P/E ratio?

Bristol-Myers Squibb's price-to-earnings ratio is 78.6, based on trailing twelve-month diluted EPS of $4.55.

Does Bristol-Myers Squibb pay a dividend?

Yes. Bristol-Myers Squibb declared $2.51 per share in dividends over the last four quarters, a yield of 0.70%.

Sources and methodology

Fundamentals come from Bristol-Myers Squibb Company's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures